Australian Trade Distributors Stock News

Andean Silver (ASX:ASL) has drawn fresh attention after presenting at the PDAC Conference 2026 in Toronto, where management focused on progress at its Cerro Bayo silver gold project in southern Chile. See our latest analysis for Andean Silver. That increased visibility at PDAC comes after a strong run in Andean Silver’s shares, with a 7 day share price return of 14.02% and a 90 day share price return of 16.75%, while the 1 year total shareholder return sits around 7x and the 3 year total...

Boss Energy Limited has reported half-year results to December 31, 2025, with sales of A$81.82 million up from A$47.79 million a year earlier, and a reduced net loss of A$7.92 million versus A$9.5 million previously. The combination of higher sales and a smaller loss suggests that recent operational efforts may be improving the company’s underlying performance, even though it remains loss-making. We’ll now examine how Boss Energy’s stronger half-year sales performance and reduced loss might...

Wesfarmers recently reported half-year results for the period to 31 December 2025, with sales of A$24,212 million and net income of A$1,603 million, and confirmed a cash dividend of A$1.02 per share for shareholders on the register as of 25 February 2026. The uplift in basic earnings per share from A$1.294 to A$1.414 highlights improved profitability over the period, underpinning the board’s decision to maintain a meaningful interim cash return. We’ll now explore how this earnings...

Life360 (ASX:360) has capped FY 2025 with fourth quarter revenue of US$146 million and basic EPS of US$0.55, alongside net income excluding extra items of US$130 million. The company has seen revenue move from US$116 million and basic EPS of US$0.04 in Q4 FY 2024 to US$146 million and US$0.55 in Q4 FY 2025, while trailing twelve month basic EPS shifted from a loss of US$0.02 to a profit of US$0.65 as net income excluding extra items rose from a loss of US$5 million to a profit of US$151...

Nine Entertainment Co. Holdings Limited reported half-year 2025 results showing sales of A$1,060.01 million and net income of A$897.17 million, alongside declaring an ordinary dividend of A$0.045 per share for the six months to December 31, 2025, payable on April 23, 2026. The sharp uplift in earnings per share compared with the prior year, combined with a higher dividend, points to significantly improved profitability and cash distribution capacity over the period. We’ll now examine how...

Helia Group Limited recently reported that for the year ended 31 December 2025, net income rose to A$244.9 million with higher earnings per share, while the board declared a fully franked final ordinary dividend of A$0.16 and a partially franked special dividend of A$0.67 per share, both payable on 26 March 2026. At the same time, Helia guided fiscal 2026 insurance revenue to a A$320 million–A$370 million range and continued to return excess capital via large dividends, even as it faces...

Light & Wonder (LNW) shares were in focus after the company reported fourth quarter and full year 2025 results, combining higher revenue with weaker profitability and the completion of a large share buyback program. See our latest analysis for Light & Wonder. The earnings release and confirmation of the completed US$1,164 million buyback appear to be the main drivers behind recent trading. Light & Wonder’s 1 day share price return of 3.56% comes after a 30 day share price return decline of...

ARB Corporation Limited reported half-year 2025 results showing revenue of A$362.21 million and net income of A$42.17 million, and declared a fully franked A$0.34 per share dividend for the six months to 31 December 2025, payable on 17 April 2026. At the same time, Meyer Distributing announced an exclusive U.S. wholesale distribution partnership for ARB’s new Ascent Truck Cap, potentially broadening ARB’s access to American truck owners through faster nationwide delivery. Next, we’ll examine...

Atlas Arteria (ASX:ALX) has drawn attention after reporting full year 2025 results, with revenue of A$160 million, net income of A$259.5 million and earnings per share easing alongside a 20 cent second half distribution declaration. See our latest analysis for Atlas Arteria. Atlas Arteria’s A$4.76 share price reflects a modest 1-year total shareholder return of 2.42%, while the 3-year total shareholder return decline of 11.16% suggests momentum has been softer despite the latest earnings and...

Paladin Energy Ltd. has received Ministerial approval for its Environmental Impact Statement under Saskatchewan’s Environmental Assessment Act, clearing a key regulatory hurdle for developing the shallow, high-grade Patterson Lake South uranium project in Canada’s Athabasca Basin. This approval is a prerequisite for future construction and operating permits, meaning regulatory risk around one of Paladin’s core growth assets has materially reduced. We’ll now examine how Ministerial approval...

APA Group (ASX:APA) has just received Australian Energy Regulator approval for A$459.5 million in regulated revenue from its Basslink interconnector over four years, which reshapes the certainty and risk profile around this core asset. See our latest analysis for APA Group. APA’s latest share price of A$9.29 comes after a 4.85% 1 month share price return and a 2.77% year to date share price gain. The 1 year total shareholder return of 33.18% points to stronger momentum over a longer...

Regis Resources (ASX:RRL) has caught investor attention after reporting half year 2025 earnings with sales of A$1,088.05 million and net income of A$322.75 million, alongside a fully franked interim dividend. See our latest analysis for Regis Resources. Those earnings and the fully franked interim dividend arrive after a strong run, with a 30 day share price return of 18.36% and a 1 year total shareholder return of 198.26%. However, the 1 day share price return of a 2.25% decline hints at...

In February 2026, Lynas Rare Earths reported half-year results to 31 December 2025 showing sales of A$413.69 million and net income of A$80.21 million, while Malaysia renewed the company’s operating license for 10 years with conditions to halt radioactive waste production by 2031 and treat existing waste. The sharp jump in profitability alongside a longer-dated but more tightly conditioned Malaysian license reshapes how investors may weigh Lynas’s regulatory risk against its operational...

Technical momentum puts Evolution Mining (ASX:EVN) in focus Recent technical reports flag Evolution Mining (ASX:EVN) as a stock with strong price momentum and rising demand, a pattern that appears to mirror the sharp pickup in investor interest. For you, this kind of momentum driven attention can be a prompt to look more closely at how the company’s fundamentals and valuation line up with its recent share price moves. See our latest analysis for Evolution Mining. Evolution Mining’s recent...

Pantoro Gold Limited (ASX:PNR) announced on 23 February 2026 that it had authorized an on-market share repurchase program of up to 38,344,473 shares, or 9.73% of its 394,180,907 shares on issue, running until 9 March 2027. This sizeable buyback capacity gives Pantoro Gold flexibility to adjust its capital structure over time, potentially increasing the ownership percentage of remaining shareholders if the program is executed. We will now examine how Pantoro Gold’s sizable share repurchase...

Perenti Limited recently reported half-year 2025 results showing broadly flat revenue of A$1,728.68 million and a modest increase in net income to A$58.34 million, alongside a higher unfranked interim dividend of A$0.0325 per share payable in April 2026. At the same time, the company trimmed the upper end of its fiscal 2026 revenue and EBIT guidance ranges and disclosed the upcoming resignation of Non-executive Director Tim Longstaff, adding a layer of uncertainty around its medium-term...

Earnings trigger and why Neuren is on radar Neuren Pharmaceuticals (ASX:NEU) has come into focus after releasing its full year 2025 results, reporting revenue of A$84.84 million and net income of A$30.44 million, both lower than the prior year. See our latest analysis for Neuren Pharmaceuticals. The share price reaction has been sharp, with a 1 day share price return of an 8.79% decline and a 30 day share price return of a 24.75% decline. The 1 year total shareholder return of 1.87% and 3...

Viva Energy Group Limited has reported full-year 2025 results showing sales of A$28.53 billion and a net loss of A$421.1 million, while also declaring a fully franked ordinary dividend of A$0.0394 per share for the six months to 31 December 2025, payable on 31 March 2026. The combination of a much larger loss and the decision to maintain a fully franked dividend raises important questions about Viva Energy’s earnings quality, cash generation, and approach to shareholder returns. We’ll now...

Cochlear has launched the Cochlear Nucleus Nexa System, described as the world's first smart cochlear implant with upgradeable firmware and on-implant memory for securely stored, personalized hearing settings, now available in India from 1 March 2026. This marks a meaningful step in digitising hearing care, potentially making future sound processor upgrades simpler and more efficient for both patients and clinicians. We’ll now examine how this smart, upgradeable implant platform could...

Elsight (ASX:ELS) has reported its full year 2025 results, with sales of US$22.8 million and net income of US$7.48 million, a shift from the prior year’s net loss. See our latest analysis for Elsight. The latest full year results arrive alongside very strong share price momentum. A 1 day share price return of 8.67% and a 90 day share price return of 170.53% have helped lift the 1 year total shareholder return to a very large gain, which suggests investors have rapidly reappraised both growth...

Why Mesoblast’s latest guidance matters for shareholders Mesoblast (ASX:MSB) has just paired a detailed half year earnings update with new revenue guidance for its key product Ryoncil, giving investors fresh numbers on both recent performance and management expectations. The company reported half year revenue of US$51.34 million and a net loss of US$40.16 million, and now forecasts full year 2026 Ryoncil net revenue between US$110 million and US$120 million. See our latest analysis for...

Telix Pharmaceuticals (ASX:TLX) has entered an AI research collaboration with University Hospital Essen focused on PSMA-PET imaging in prostate cancer. The partnership will use Telix’s AI tools and the PROMISE-PET registry to build prognostic models for prostate cancer imaging. Telix has also submitted a European marketing authorization application for TLX101-Px, an advanced glioma imaging candidate. The glioma submission aims to address the need for more consistent, high-quality brain...

Mineral Resources (ASX:MIN) has drawn fresh attention after reporting half year earnings to 31 December 2025, with sales of A$3,052 million and net income of A$495 million, compared with a net loss a year earlier. See our latest analysis for Mineral Resources. The earnings rebound sits alongside a 26.5% 90 day share price return and a very large 1 year total shareholder return of about 2.5x, while the 3 year total shareholder return remains negative. This suggests that momentum is building...

TPG Telecom Limited recently reported full-year 2025 results, with revenue of A$5,041 million and net income of A$461 million, and declared an ordinary dividend of A$0.09 per share for the six months ended 31 December 2025, payable on 2 April 2026 to shareholders on record as of 6 March 2026. The return to profit, alongside network coverage expansion to 98.5% of the population and growing mobile service revenue from digital-first brands, highlights how TPG Telecom is converting past...